pantoprazole has been researched along with Neurologic Voice Disorder in 6 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Laryngopharyngeal reflux is a prevalent, not well-understood disease affecting a high proportion of patients who seek laryngology consultation." | 1.43 | Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study. ( Delvaux, V; Fourneau, AF; Harmegnies, B; Huet, K; Khalife, M; Lechien, JR; Piccaluga, M; Saussez, S, 2016) |
| "Gastroesophageal reflux (GER) is associated with a variety of laryngopharyngeal signs and symptoms." | 1.31 | Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. ( Fuleihan, N; Hamdan, AL; Sharara, AI; Younes, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lechien, JR | 3 |
| Finck, C | 2 |
| Huet, K | 3 |
| Khalife, M | 3 |
| Fourneau, AF | 3 |
| Delvaux, V | 3 |
| Piccaluga, M | 3 |
| Harmegnies, B | 3 |
| Saussez, S | 3 |
| Hill, RK | 1 |
| Simpson, CB | 1 |
| Velazquez, R | 1 |
| Larson, N | 1 |
| Habermann, W | 1 |
| Eherer, A | 1 |
| Lindbichler, F | 1 |
| Raith, J | 1 |
| Friedrich, G | 1 |
| Hamdan, AL | 1 |
| Sharara, AI | 1 |
| Younes, A | 1 |
| Fuleihan, N | 1 |
6 other studies available for pantoprazole and Neurologic Voice Disorder
| Article | Year |
|---|---|
Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Esophageal pH Monitoring; Esophag | 2017 |
Voice Quality as Therapeutic Outcome in Laryngopharyngeal Reflux Disease: A Prospective Cohort Study.
Topics: Acoustics; Diet, Healthy; Female; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Pantoprazole; | 2020 |
Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Female; Humans; Laryngopharyngeal Reflux; Lary | 2016 |
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2004 |
Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; | 1999 |
Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophag | 2001 |